Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Systemic agents like cyclosporine, methotrexate, and acitretin help manage psoriasis but have significant side effects.

Nanomedicines could offer better, longer-lasting psoriasis treatments with fewer side effects.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Dupilumab may help regrow hair in people with atopic dermatitis.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Dupilumab can both heal and cause hair loss.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Abrocitinib may effectively treat stubborn alopecia universalis.